2024 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Current study results on Cardiovascular Diseases and Conditions - Thrombosis have been published. According to ...
12 month closure rates for the VenaSeal closure system comparable to radiofrequency ablation DUBLIN, Medtronic plc today announced the twelve-month results of the VeClose pivotal study, which ...
DUBLIN and LONDON - April 17, 2019-Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., ...
Medical device major Medtronic plc MDT recently unveiled 12-month results from its VeClose study, validating the clinical durability of its VenaSeal closure system, at the European Venous Forum 2015 ...
Please provide your email address to receive an email when new articles are posted on . The FDA today announced its approval of the VenaSeal closure system to permanently treat varicose veins of the ...
The U.S. Food and Drug Administration (FDA) has recently cleared Medtronic plc's (MDT) VenaSeal closure system for use in the treatment of patients in the U.S., who suffer from venous reflux disease, ...
Please provide your email address to receive an email when new articles are posted on . Patients with symptomatic refluxing great saphenous veins treated by a closure procedure or radiofrequency ...
The U.S. Food and Drug Administration (FDA) announced on Friday, Feb. 20, the approval of permanent varicose vein treatment VenaSeal, a closure system that seals affected superficial veins with a ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Sapheon Inc. announced it has received approval from Health Canada for the VenaSeal® Sapheon Closure System, a new treatment for venous reflux disease (varicose ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Sapheon Inc. announced today that it submitted the first module of the pre-market approval (PMA) application for the VenaSeal® Sapheon Closure System to the U.S.
The latest data from Medtronic ($MDT) demonstrate just how wide its market reach extends. It found that a recently approved adhesive treatment for chronic venous ...